A business in context

BIOE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-090174

  2. 8-K/A · Current report

    Report date 2026-04-24 · 0001213900-26-058985 · Items 1.01,9.01

  3. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-057529

  4. 8-K · Current report

    Report date 2026-04-24 · 0001213900-26-047207 · Items 1.01,9.01

  5. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-035467

  6. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-108357

  7. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-076353

  8. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001213900-25-043524

  9. 10-K · Annual report

    Report date 2024-12-31 · 0001013762-25-003850

  10. 10-Q/A · Quarterly report

    Report date 2024-06-30 · 0001213900-24-103410

  11. 10-Q/A · Quarterly report

    Report date 2024-03-31 · 0001213900-24-103408

  12. 4 · Ownership change

    Report date 2024-10-28 · 0001213900-24-099693

  13. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001213900-24-098180

  14. 10-Q/A · Quarterly report

    Report date 2024-06-30 · 0001213900-24-091885

  15. 10-Q/A · Quarterly report

    Report date 2024-03-31 · 0001213900-24-091884

  16. 4/A · Ownership change

    Report date 2023-06-06 · 0001213900-24-087183

  17. 4 · Ownership change

    Report date 2024-07-11 · 0001213900-24-087036

  18. 4/A · Ownership change

    Report date 2024-07-02 · 0001213900-24-086923

  19. 10-Q/A · Quarterly report

    Report date 2024-03-31 · 0001213900-24-085881

  20. 8-K · Current report

    Report date 2024-10-07 · 0001213900-24-085841 · Items 4.02

  21. 10-Q/A · Quarterly report

    Report date 2024-06-30 · 0001213900-24-071418

  22. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001213900-24-070806

  23. 8-K/A · Current report

    Report date 2024-08-05 · 0001213900-24-067237 · Items 4.01,9.01

  24. 8-K · Current report

    Report date 2024-08-05 · 0001213900-24-065237 · Items 4.01

  25. 4 · Ownership change

    Report date 2024-07-02 · 0001213900-24-062097

  26. 8-K · Current report

    Report date 2024-06-18 · 0001213900-24-054715 · Items 5.02,8.01,9.01

  27. 4 · Ownership change

    Report date 2023-06-06 · 0001213900-24-049108

  28. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001213900-24-044667

  29. 10-K · Annual report

    Report date 2023-12-31 · 0001213900-24-032898

  30. 8-K · Current report

    Report date 2024-04-04 · 0001213900-24-030435 · Items 1.01,9.01

  31. 8-K · Current report

    Report date 2023-12-13 · 0001213900-23-095369 · Items 1.01,5.02

  32. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001213900-23-085846

  33. 8-K · Current report

    Report date 2023-09-07 · 0001213900-23-074954 · Items 5.02

  34. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001213900-23-066865

  35. 8-K · Current report

    Report date 2023-06-06 · 0001213900-23-046864 · Items 8.01,9.01

  36. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001213900-23-039043

  37. 10-K · Annual report

    Report date 2022-12-31 · 0001213900-23-024571

  38. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001213900-22-071931

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001723059Bio Essence Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$323.9K$344.8K
    2023-12-31$551.5K$604.3K
    2022-12-31$621.6K$709.1K
    2021-12-31$888.0K$1.09M
    2020-12-31$958.7K$1.24M

    Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

    Explore the CPI history ↗